ATE521359T1 - Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall - Google Patents

Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall

Info

Publication number
ATE521359T1
ATE521359T1 AT05726549T AT05726549T ATE521359T1 AT E521359 T1 ATE521359 T1 AT E521359T1 AT 05726549 T AT05726549 T AT 05726549T AT 05726549 T AT05726549 T AT 05726549T AT E521359 T1 ATE521359 T1 AT E521359T1
Authority
AT
Austria
Prior art keywords
stroke
prevention
extract
treatment
disease
Prior art date
Application number
AT05726549T
Other languages
English (en)
Inventor
Ho Chol Kim
Young Min Boo
Original Assignee
Neumed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neumed Inc filed Critical Neumed Inc
Application granted granted Critical
Publication of ATE521359T1 publication Critical patent/ATE521359T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05726549T 2005-01-25 2005-01-25 Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall ATE521359T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2005/000199 WO2006080590A1 (en) 2005-01-25 2005-01-25 Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases

Publications (1)

Publication Number Publication Date
ATE521359T1 true ATE521359T1 (de) 2011-09-15

Family

ID=36740592

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05726549T ATE521359T1 (de) 2005-01-25 2005-01-25 Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall

Country Status (5)

Country Link
US (2) US7648718B2 (de)
EP (1) EP1846011B1 (de)
JP (1) JP2008528481A (de)
AT (1) ATE521359T1 (de)
WO (1) WO2006080590A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008003467A1 (de) * 2008-01-02 2009-09-10 Eiden, Martin, Dr. Flavonoide als Mittel zur Prophylaxe und Behandlung von neurodegenerativen und anderen Proteinfehlfaltungskrankheiten
US8574639B2 (en) 2010-08-17 2013-11-05 ILHWA Co., Ltd. Fermented ginseng concentrate having IH-901
WO2012074043A1 (ja) * 2010-12-03 2012-06-07 国立大学法人 岡山大学 外傷性神経障害治療剤
CN102526234A (zh) * 2011-12-03 2012-07-04 范文忠 一种治疗中风的药物及其制备方法
KR101415697B1 (ko) 2012-08-28 2014-07-04 (주)뉴메드 산사 및 진피의 복합 추출물을 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 치료 또는 예방용 약학 조성물
KR101486857B1 (ko) 2013-06-11 2015-01-28 (주)뉴메드 지황 및 갈근의 복합 추출물을 함유하는 갱년기 증상의 예방 또는 치료용 조성물
KR101548050B1 (ko) * 2013-10-08 2015-08-27 경희대학교 산학협력단 갈근 및 황금의 복합 추출물을 유효성분으로 함유하는 뇌졸중 및 퇴행성 뇌질환의 예방 또는 치료용 약학적 조성물
EP3997113A4 (de) * 2019-10-02 2023-06-28 Chiaranussati, Suchad Humusbehandlungsverfahren mit aktiven neurologischen substanzen
CN113640427B (zh) * 2021-08-23 2023-05-16 神威药业集团有限公司 一种小续命汤标准汤剂中指标成分的定量检测方法及应用
CN114209784B (zh) * 2021-12-29 2023-04-25 江苏省中医院 一种基于芳香疗法辅助睡眠的中药调神组合物及香囊

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6464263A (en) * 1987-09-03 1989-03-10 Toshiba Corp Semiconductor device and its manufacture
JP3126162B2 (ja) 1991-03-26 2001-01-22 哲郎 毛利 神経細胞賦活物質の製法
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
KR20000006625A (ko) 1998-07-20 2000-02-07 묵인희 인삼추출물을 포함하는 치매 치료제
AU5425400A (en) 1999-04-12 2000-11-14 University Of Madras A pharmaceutical formulation useful for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation
AU4147800A (en) * 1999-04-13 2000-11-14 Biosynergen, Inc. Composition for preventing or treating dementia comprising hydroxycinnamic acid derivative or an extract of a plant of genus (angelicae) containing same
JP2001139483A (ja) * 1999-08-30 2001-05-22 Japan Science & Technology Corp 薬用人蔘からなる脳細胞または神経細胞保護剤
EP1213026A4 (de) * 1999-08-30 2004-06-16 Japan Science & Tech Agency Gehirn- oder nervenzellen schützende wirkstoffe die ginseng enthalten
KR100364383B1 (ko) * 2000-02-10 2002-12-18 김호철 신경보호작용을 갖는 황금추출물 및 이를 함유하는 약학적제제
AU2002247876A1 (en) * 2000-11-22 2002-08-12 Yong Chao Xia Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
KR100458131B1 (ko) 2001-04-02 2004-12-03 경희대학교 산학협력단 신경보호작용을 갖는 가시오가피 추출물 및 이를 함유하는약학적 제제
KR20020078850A (ko) 2001-04-10 2002-10-19 김호철 신경보호작용을 갖는 당귀추출물 및 이를 함유하는 약학적제제
WO2003006039A1 (en) 2001-07-11 2003-01-23 Regen Biotech, Inc. A composition for the protection and regeneration of nerve cells containing the extract of scutellaria radix
US6447814B1 (en) * 2001-08-28 2002-09-10 Yung Shin Pharma Ind. Co. Ltd. Chinese herbal composition for improving blood circulation and the method of preparing the same
KR100472380B1 (ko) 2001-12-18 2005-03-08 나승열 인삼 진세노사이드를 함유하는 카이네이트에 의한 해마씨추체신경세포의 사멸 또는 손상의 예방 및 치료용 조성물
KR20040036451A (ko) * 2002-10-26 2004-04-30 한국과학기술연구원 진세노사이드 Ｒｇ３ 또는 진세노사이드 Ｒｈ２를포함하는 글루타메이트 매개 신경독성 억제 조성물
JP2004238310A (ja) * 2003-02-05 2004-08-26 Ichimaru Pharcos Co Ltd 化粧料組成物又は飲食品
KR20040079265A (ko) 2003-03-07 2004-09-14 김형환 데커신 또는 데커시놀 안젤레이트를 함유하는 혈관질환예방 또는 치료용 혈관이완제
US20040185121A1 (en) * 2003-03-21 2004-09-23 Yu Li Cheng Chinese herbal medicine composite system for use in treatment of paralysis
KR20050014710A (ko) 2003-07-30 2005-02-07 성광수 오가피 추출물을 포함하는 치매 예방 또는 치료용 조성물
JP4803969B2 (ja) * 2004-03-31 2011-10-26 小林製薬株式会社 植物抽出物を含有する粒剤の製造方法
US20060068032A1 (en) * 2004-09-24 2006-03-30 Sunny Biodiscovery, Inc. Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of Angelica sinensis, and methods of preparation thereof

Also Published As

Publication number Publication date
US20100055213A1 (en) 2010-03-04
US8241679B2 (en) 2012-08-14
WO2006080590A1 (en) 2006-08-03
EP1846011A4 (de) 2008-09-10
EP1846011B1 (de) 2011-08-24
US7648718B2 (en) 2010-01-19
EP1846011A1 (de) 2007-10-24
JP2008528481A (ja) 2008-07-31
US20080131530A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
ATE521359T1 (de) Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall
Singh et al. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders
Howes et al. Effect of Chinese herbal medicine on Alzheimer's disease
Gao et al. Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease
Wagner Natural products chemistry and phytomedicine in the 21st century: new developments and challenges
Wang et al. Saponin accumulation in flower buds of Panax notoginseng
WO2007127393A3 (en) Treatment and screening methods for promoting neurogenesis
Khan et al. Ginsenosides as food supplements and their potential role in immunological and neurodegenerative disorders
Um et al. In vitro screening of the acetylcholinesterase inhibition, antioxidant activity, and neuronal cell protective effect of medicinal plant extracts
Kwak et al. Protective effects of black soybean seed coat extracts against oxidative stress-induced neurotoxicity
Park et al. Protective effects of Glycyrrhiza uralensis Radix extract and Its active compounds on H 2 O 2-induced apoptosis of C6 glial cells
김지현 et al. Protective effects of Cirsium japonicum var. maackii against amyloid beta-induced neurotoxicity in C6 glial cells
Adewusi et al. Medicinal plants and their derivatives with amyloid beta inhibitory activity as potential targets for drug discovery
Kim Regulation of neural stem cell fate by natural products
Kim et al. Systemic review on the research trend of Gastrodiae rhizoma and relationship between the herbology and KCD-code
Amtul Nutraceuticals neuroprotect naturally: Alzheimer’s disease, Parkinson’s disease, stroke and major depressive disorder
RU2012131139A (ru) Растительные экстракты для лечения нейродегенеративных заболеваний
Baral et al. Effects of Gastrodiae rhizoma on proliferation and differentiation of human embryonic neural stem cells
Nathan et al. Asiatic Acid and Madecassic Acid Promote Neurite Outgrowth in Neuro2a Cell
Perera et al. Traditional Medicinal Plants of Sri Lanka and Their Derivatives of Benefit to the Nervous System
CN102453074B (zh) 五环三萜类皂苷及其用途
KR20160149853A (ko) 퇴행성 뇌질환 예방 또는 치료용 약학 조성물
Sithisarn et al. Anti-inflammatory and antioxidative effects of leaf extract from Acanthopanax trifoliatus
Kim et al. Conversion of ginsenosides by 9 repetitive steamings and dryings process of Korean ginseng root and its inhibition of BACE-1 activity
Baral et al. Effects of Schisandrae fructus 70% ethanol extract on proliferation and differentiation of human embryonic neural stem cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties